KarXT
CN012-0038
Phase 3 small_molecule active
Quick answer
KarXT for Bipolar Disorder Type I With Mania is a Phase 3 program (small_molecule) at Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bristol-Myers Squibb
- Indication
- Bipolar Disorder Type I With Mania
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active